Panbela Therapeutics Inc. (PBLA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.37
0.01 (1.37%)
At close: Jan 15, 2025, 3:58 PM
0.37
0.54%
Pre-market Jan 02, 2025, 09:30 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
PE Ratio | -0.00 | -0.04 | -2 | -5.77 | -3.86 | -55.27 | -68.73 | -0.35 | -0.67 | -0.27 | -0.12 | 0.11 | -0.19 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.02 | 0.03 | 0.02 | 0.04 |
PB Ratio | -0.00 | -0.19 | 1.98 | 3.26 | 17.29 | 1.22K | -193.29 | -0.39 | -1.22 | -0.14 | -0.19 | -0.65 | -0.07 |
P/FCF Ratio | -0.00 | -0.09 | -3.02 | -7.14 | -8.74 | -136.72 | -209.59 | -0.75 | -0.84 | -2.51 | -0.65 | 0.71 | -0.32 |
P/OCF Ratio | -0.00 | -0.1 | -3.02 | -7.14 | -8.74 | -136.72 | -209.59 | -0.75 | -0.84 | -2.51 | -0.75 | 0.71 | -0.36 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.01 | -0.04 | 0.03 | -0.1 |
Debt / Equity Ratio | -1.1 | -0.85 | n/a | n/a | 0.08 | 1.31 | -0.49 | -0.71 | -1.24 | -2.73 | -4.22 | -14.35 | -1.4 |
Quick Ratio | 0.25 | 0.23 | 4.62 | 7.15 | 1.76 | 1.13 | 0.18 | 0.16 | 1.26 | 0.64 | 0.65 | 0.52 | 0.37 |
Current Ratio | 0.25 | 0.23 | 4.62 | 7.15 | 1.76 | 1.13 | 0.18 | 0.16 | 1.26 | 0.64 | 0.65 | 0.52 | 0.37 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.33 | 1.83 | 2.02 | 2.76 |
Interest Coverage | 161.81 | -118.38 | -910 | -338.47 | -1.97 | -2.14 | -3.72 | -28.71 | -29.75 | -2.12 | -5.41 | 7.82 | -3.05 |
Return on Equity (ROE) | 5.36 | 4.34 | -0.99 | -0.56 | -4.48 | -22.03 | 2.81 | 1.10 | 1.84 | 0.51 | 1.54 | -6.06 | 0.34 |
Return on Assets (ROA) | -2.14 | -7.02 | -0.79 | -0.49 | -1.97 | -3.11 | -13.53 | -5.83 | -2.73 | -0.26 | -0.4 | 0.40 | -0.54 |
Return on Capital (ROIC) | 99.41 | 11.94 | -0.98 | -0.68 | -3.12 | -14.52 | 1.77 | 1.11 | -12.57 | 0.36 | 1.48 | -8.68 | 0.26 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 56.14% | 42.65% | 43.88% | 21.32% |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.89% | -21.77% | 20.07% | -19.77% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.88% | -21.75% | 20.09% | -19.75% |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.56% | -19.95% | 22.94% | -14.93% |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.84% | -4.16% | 3.01% | -11.8% |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.56% | -19.95% | 23.48% | -14.49% |